Below is a listing of webinars for our biopharma customers that have been created collaboratively by QuintilesIMS Global Marketing and business unit leadership and subject matter experts.

Previous Webinars

2016 Webinars

  • The State of Risk-based Monitoring (RBM)
    Tuesday, June 21, 2016 
    Speakers: Martin Giblin and Alan Frederickson
  • Understanding Care Pathways- Drivers, Development and Successful Implementation
    Thursday, June 23, 2016 
    Speakers: Jonathan Morris MD and Barbara Arone MS
  • Strategic Considerations for Clinical Development Programs in Emerging Biopharma
    Wednesday, May 25, 2016
    Speaker: Rick Sax, M.D.
  • Update: Post Authorization Safety Studies landscape, the 2010 EU PV Legislation and impact on today’s observational post-marketing studies
    Wednesday, May 18, 2016 
    Speakers: Priscilla Velentgas and Pierre Engel, PharmD, MPH, PhD
  • Precision Asset Valuation: Leveraging Insights from Clinical and Market Access Big Data
    Tuesday, May 11, 2016
    Speakers: Bruce Basson, Peter Wagner and Bob Humphries
  • Medical Science Liaisons: Optimizing their impact during product launch
    Tuesday, May 03, 2016
    Speakers: Peter Rutherford and Todd J. Yancey
  • Achieving Operational Excellence in Prospective Observational Research
    Thursday, April 21, 2016
    Speakers: Louise Parmenter and Ombretta Palucci
  • Immuno-Oncology Insights: Top 5 Challenges in Today’s Immuno-Oncology Trials
    Thursday, April 07, 2016
    Speakers: Eric Groves, Matthew Bentley and Kathleen Gray
  • Overcoming Regulatory and Statistical Hurdles of Biosimilars Drug Development: Designing Smarter Trials
    Wednesday, April 06, 2016
    Speakers: Kamali Chance and Russell Reeve
  • Adaptive pathways: Improving timely access for patients to new treatments
    Thursday, March 31, 2016
    Speakers: Dr. Stella Blackburn and Janice Haigh
  • Mitigating Risk using Risk-based Monitoring
    Tuesday, March 22, 2016
    Speakers: Dr. Jonas Renstroem and Edward Tumaian
  • The registry of the future: Leveraging EHR and patient data to drive better outcomes
    Wednesday, February 17, 2016
    Speakers: Brian J. Kelly, M.D., Jason Colquitt

2015 Webinars

  • U.S. Market Access: Key learnings from a recent success story
    Thursday, November 19, 2015
    Speakers: Randolph Carpio and Joe Bonaccorso
  • Considerations for real-world approaches for biosimilar evidence generation needs
    Wednesday, November 18, 2015
    Speakers: Jaclyn Basco and Kamali Chance
  • How intelligent is your multichannel strategy?
    Wednesday, November 04, 2015
    Speakers: Drew Romes and Kyu Om
  • From retrospective to prospective study designs: leveraging clinical, administrative, and patient reported data for clinically meaningful research
    Thursday, October 29, 2015
    Speakers: Jennifer Christian and David Thompson
  • The Impact of Risk-based Monitoring on Site Performance
    Wednesday, September 16, 2015
    Speakers: Yvonne Barnes and Robin Douglas
  • Using Predictive and Advanced Analytics to Enhance Risk-based Monitoring (RBM)
    Thursday, September 3, 2015 
    Speakers: Rajneesh Patil and XiaoQiang Xue
  • Data Management Considerations in Observational Studies
    Thursday, August 20, 2015
    Speakers: Zia Haque and Valerie Alward
  • Strategies for success in conducting post-authorization vaccine studies and surveillance activities
    Friday, July 24, 2015
  • Using Real-World Data for Outcomes Research and Comparative Effectiveness Studies
    Thursday, July 23, 2015
  • On the road to integration: moving your multichannel program into the fast lane
    Wednesday, July 1, 2015 
    Speakers: Peter Lammers and Liz Murray
  • Breaking through the complexity: improving oncology treatment and access in the UK
    Tuesday, June 30, 2015
    Speakers: Dean Summerfield and Dr Jason Lester
  • Integrated lab data driving new, faster patient insights for Risk-based Monitoring (RBM) approaches
    Tuesday, June 23, 2015
    Speakers: Rajneesh Patil and Annette Williams
  • Patient adherence in Germany - benefit versus cost containment
    Monday, June 24, 2015
    Speakers: Joanne Thiele + Hans Holger Bless (Director IGES Institute)
  • Demystifying genomics for drug developers
    Tuesday, May 19, 2015
    Speakers: Klaus Gottlieb
  • Considerations for Formally Validating Software in Laboratories Supporting of CLIA Genomic Assays
    Wednesday, June 3, 2015
    Speakers: Vic Weigman
  • Retain patients in real-world studies to improve evidence collection with increased engagement
    Wednesday, June 10, 2015
    Speakers: Nancy Dreyer, PhD, MPH; John Reites, and Marlene Smurzynski, PhD, MSPH
  • Embedding Patient Centricity-Understanding the role of real-world evidence in global market access strategies
    Tuesday, April 28, 2015
    Speakers: Dr. Louise Parmenter and Dr. Stella Blackburn
  • Generate Evidence for Medical Breakthroughs and Unmet Treatment Needs in Rare Disease Research
    Thursday May 14, 2015
  • Value Vigilance: A Transformative Approach to Managing Safety and Regulatory for Established Products
    Tuesday April 2, 2015
    Speakers: Matthew McKeever, M.D., FAAP & James C. Walker, CEO and Founder, Octagon Research Solutions, Inc.
  • Risk-based Monitoring Requires Changes to Leverage Data Insights
    Tuesday March 31, 2015
    Speakers: Yvonne Barnes; Rajneesh Patil
  • Emerging Biopharma: Designing Smarter, More Predictable Clinical Trials
    Wednesday March 25, 2015
    Speakers: Seth Berry, PharmD; Lara Marquis; & Cara Willoughby
  • Lessons Learned on the Application and Implementation of PASS & PAES
    Tuesday March 5, 2015
    Speakers:Michelle Bulliard, RN, BScN; Dr. Stella Blackburn
  • Oral Oncology Therapies: Meeting New Challenges in Patient Adherance
    Tuesday, January 27, 2015
    Speakers: Susue Newton, RN, MS. AOCN, AOCNS; Cheryl Fowler, ASN, BSN; Nicole Korak, RN, BSN
  • ABCs of Value-Based Care: Implications of Research
    Tuesday, January 20, 2015
    Speakers: Dr. Francis Zavier Campion
2014 Webinars
  • Evolving Benefit-Risk Management: A new approach to benefit-risk assessments
    December 16, 2014
    Speakers: Dr. Stella Blackburn and Mary Mease
  • A New Method for Standardizing Flow Cytometry
    December 10, 2014
    Speakers: Mark Edinger
  • UK payer perspectives: The value paradox (part III)
    December 10, 2014
    Speakers: Ryan Wooler and Dr. Junaid Bajwa
  • Improving the Quality of Allergy & Respiratory Clinical Research Using Induced Sputum Biomarkers
    December, 2014
    Speakers: Graham Clarke and Neil Alexis
  • Emerging Biopharma: Optimizing Your Clinical Trials for Better Outcomes 7 Best Use of Available Funding
    November 19, 2014
  • Early Clinical Insights: Harmonizing Methodologies to Improve Allergy & Respiratory Research
    November 14, 2014; Speakers: Graham Clarke PhD and Alexis Register
  • Vaccine Trials in Latin America: Insights and Opportunities
    November 13, 2014
    Watch or contact Zoe Fenwick
  • Evolving Role of the Medical Field Force-Asia Pacific
    November 11, 2014
    Watch or contact Zoe Fenwick
  • Evolving Benefit-risk Management: A New Approach to Benefit-Risk Assessments
    Amsterdam, The Netherlands; November 8-12, 2014
  • Patient-Centric Pharmacovigilance: Building Better Outcomes through Integrated Technology
    October 29, 2014
  • Seizing the Future in Oncology: Improving the Clinical Development of Immunotherapies
    October 23, 2014
    Speakers: Chris Learn, Eric Groves, Phil Breitfeld
  • The Evolving Role of Data Management in Risk-Based Monitoring
    October 16, 2014
  • The Right Start: Optimizing Trial Recruitment Through Earlier Planning and Patient Identification
    October 2, 2014
  • Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER)
    September 11, 2014
  • The Evolution of RNA-Sequencing
    August 22, 2014
  • Early Clinical Insights: Best Practices for Optimizing Dose Escalation in First in Human Studies
    August 6, 2014
    Speakers: Professor Tim Mant and Seth Berry, PharmD
  • Time Response Modeling in Rheumatoid Arthritis and Other Autoimmune Indications
    July 23, 2014
  • Accelerated Start-Up: The Right Start to Trial Success
    July 10, 2014
  • Exome Sequencing and Analysis: Considerations for Sample Input, Capture Techniques and Pipelines related to Variant Detection
    June 25, 2014
  • Targeted Oncology Biomarker Solutions in the Elucidation of Inflammatory Breast Cancer Mechanisms
    May 28, 2014
  • Rheumatoid Arthritis Treatment: Are We Doing the Best We Can?
    Wednesday, May 7, 2014
    Speakers: Dr. Iain McKinnis
  • Best practices for obtaining RNA sequencing data from Formalin-fixed Paraffin-embedded (FFPE) samples
    April 25, 2014
  • Quintiles and Amgen: Evolving Clinical Monitoring and Improving Outcomes with a Risk-based Approach
    Wednesday, April 16, 2014
    Speakers: Rachel Edwards, Alexandra Massoud and Justin Stark
  • Quintiles Right Start: Country and Site Selection
    Tuesday, April 1, 2014
    Speakers: Chris Frega, MBA and Tom Larrichio
  • Risk-based Monitoring: Using Centralized Data Surveillance to Evolve Data Review and Site Engagement
    Thursday, March 20, 2014
    Speakers: Martin Giblin and Teresa Lamantia
  • Operational Considerations for Running Effective Expanded Access Programs
    Tuesday, March 25,2014
    Speakers: Rebecca Thompson and Jean Louis-Merot
  • Lessons Learned on the Design and Implementation of Post-Authorization Safety Studies (PASS) under the New EU PV Requirements
    January 28, 2014
    Speakers: Michelle Bulliard, RN and Pierre Engel
2013 Webinars 
  • Catching Up with the Genomic Era in Oncology
    December 13, 2013
    Speakers: Phil Breitfeld and Jeff Fitzgerald
  • Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications
    December 6, 2013
  • Comprehensive Approaches to Evidence Development for Real-World and Late Phase Research
    November 19, 2013 
    Speakers: Richard Gliklich, MD and Nancy A. Dreyer, PhD, MPH
  • Best Practices in Patient Recruitment and Retention for Diabetes Trials
    November 18, 2013
    Speakers: Erica Caveney, MD and Tracy Stewart, MBA
  • Data-driven Trial Execution: Delivering Next-Generation Risk-based Monitoring
    November 15, 2013 
    Speaker: Dan White
  • Clinical Research Landscape in Latin America
    October 23, 2013 
  • Improve Protocol Design for Diabetes Trials Using Predictive Techniques
    October 23, 2013 
    Speakers: Denise Messer, MA ; Erica Caveney; Bruce Besson, MS and Claudia de Oliveira, MD, PhD, MPH
  • Integrated Channel Management
    October 17, 2013
    Speaker: Peter Dussias
  • Better Methods for Novel Biomarkers Series: Webinar 2:   LC/MS Biomarker Assay Validation Strategies Using Surrogate Matrix and Surrogate Analyte Approaches
    October 3, 2013
    Speaker: Barry R. Jones, PhD
  • Quintiles Response to FDA Guidance on Risk-based Monitoring and Improving Data Quality
    September 30, 2013
    Speakers:Dan White and Dan Ballard
  • Planning for Success: Early Opportunities to Set the Course for Successful Global Marketing Authorization
    September 26, 2013
    Speakers: Laurie Henricks and Terry Sosa
  • Safety Evaluation in the Post-Marketing Environment: Overview and Analytical Considerations
    September 24, 2013
    Speakers: Aaron B. Mendelson, MPH, PhD and Pierre Engrl, PharmD, MPH, Epidemiologist
  • Using Effective Registries to Meet Biosimilar Research Needs
    August 21, 2013
    Speakers: Dr. Jaclyn Bosco, PhD, MPH and Kamali Chance
  • DOs and DON’Ts of Study Start-Up: Best practices to improve efficiency and meet/exceed timelines
    July 23, 2013 
    Speakers:Julie Parmelee, Nicole Turner and Michelle Archibald
  • Risk-based Thinking: From Design to Delivery
    July 19, 2013
    Speaker: Frederic L. Sax, M.D.
  • Better Methods for Novel Biomarkers Series: Webinar #1: Quantitative Analysis of Biomarkers with the Specificity and Robustness of Liquid Chromatography/Mass
    June 27, 2013
    Speaker: Gary Schultz, PhD
  • Optimize Your Product Launch in a Multi-Stakeholder Environment
    June 20, 2013
    Speaker: Troy Hampton
  • Risk-based Thinking: The Success of Risk-based Monitoring Begins with Risk-based Thinking
    June 19, 2013
  • Understanding Market Access Across Europe & How to Get Market Access Right in the UK
    June 13, 2013 
    Speakers: Janice Haigh and Gareth Williman
  • Accelerating Drug Development by Harnessing Technology
    June 07, 2013 
    Speakers: Tom Grundstrom and Kris Gustafson
  • Best Practices for Planning & Design
    May 28, 2013
    Speaker: Frederic L. Sax, M.D.
  • Oncology Molecule Value Demonstration: The Shifting Sands of Stakeholder Expectations, and the Role of Real-World Evidence
    May 28, 2013
    Speakers: John Doyle, Harish Dave and Jean-Louis Merot
  • Case Studies: Lessons Learned from Risk-based Monitoring Programs
    April 30, 2013
    Speaker: Dan White
  • Evolving Initiatives and Approaches to Meeting Rare Disease Research Needs through Effective Registries
    April 24, 2013
    Speaker: Ombretta Palucci
  • Drug-Diagnostic Co-Development Strategies for Oncology: Critical Aspects of Development and Launching an Oncology Companion Diagnostic
    April 19, 2013
    Speakers: Brad Smith and Eric Faulkner
  • Role of EMRs in Patient Registries & Other Post-Marketing Research
    March 29, 2013
    Speakers: Dr. David Thompson and Daniel Levy
  • The Role and Value of Patient Registries for Clinical Specialty and Patient Organizations
    March 20, 2013
    Speaker: Amy Donnelly
  • Model-Based Drug Development (MBDD) 101: A Primer on MBDD and Its Benefits
    February 28, 2013
    Speakers: Russ Reeve and Seth Berry
  • Generating Evidence for Medical Devices for Supporting Market Approval and Monitoring Safety Post-Approval
    February 27, 2013
    Speakers: Dr. David West, Daniel Campion and Dr. Nancy Dreyer
  • Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms
    February 13, 2013
    Speakers: Chris Frega and Tom Larrichio
  • Adjusting to Effectively Meet the New European Union Pharmacovigilance Requirements
    January 31, 2013
    Speakers: Michelle Bulliard and Deirdre McCarthy
  • The Registry of Patient Registries (RoPR): An Introduction
    January 1, 2013
    Speakers: Daniel Campion and Tom Taylor
2012 Webinars
  • Maximizing Quality and Efficiency of Go/No Go Decisions in Early Oncology Development
    December 15, 2012
    Speakers: Philip Breitfeld,MD; Eric Groves, MD, Ph; and Chris Learn, PhD, PMP
  • Diabetes Drug Development: A Perspective on Pediatric Indication Planning
    December 13, 2012
    Speakers: Cynthia Jackson, DO; Paul Strumph, MD; and Robin Huff, PhD
  • Using Real-World Databases for Evidence Development
    November 1, 2012
    Speaker: Terry Cox, MD, PhD
  • Risk-based Approach to Monitoring: The Future Roles of People, Process & Technology
    October 15, 2012
    Speakers: Thomas Grundstrom and Amanda Sax
  • Generating the Right Evidence for Market Access in the US: How do we Successfully Navigate Against a Constantly Changing Roadmap?
    October 1, 2012
    Speakers: Eric Faulkner and Louise Parmenter
  • Regulatory & Safety Operations: Unlocking Additional Value of Your Marketed Products
    September 28, 2012
    Speakers: Geoff Garabedian, Peter Lassoff, Pharm.D.; Uwe Maennl, MD, Ph.D., MBA; and Jill Buckley, Pharm.D.
  • Early Clinical Insights:Best Practices for Optimizing Dose Escalation in FIH Studies
    September 24, 2012
    Speakers: Eleanor A. Lisbon MD, MPH, CPI; Tim Mant; Steve Lowes, PhD; and N. Seth Berry, PharmD.
  • Generating the Right Evidence to Drive Market Access: Europe
    September 1, 2012
    Speakers: Anke van Engen and Louise Parmenter
  • Designing and Implementing Effective Rare Disease Registries
    August 1, 2012
    Speaker: Barbara Arone, MS
  • Maximizing Value and Quality in Phase IV Trials
    July 1, 2012
    Speakers: Cynthia Verst, PharmD, MS and Eric Gemmen
  • Medical Outcome Trials: Market Trends and Best Practice Approaches
    May 1, 2012
    Speakers: Phil Galtry and Mel Blackwood
  • Making Informed Decisions in Comparative Effectiveness Research (CER): Experimental and Non-Experimental Designs and Methods
    April 1, 2012
    Speaker: Christopher Rowan PhD.
  • Early Clinical Insights: The Case for Early Cardiac Safety 
    March 3, 2012
    Speakers: Dhiraj Narula, MD; J. Rick Turner, PhD.; Jared Schettler, MS.
  • The Right Research Approach for the Right Question
    March 1, 2012
    Speaker: Louise Parmenter PhD.
  • Design and Analytical Considerations in Registry-Based Studies: Registries 201
    February 1, 2012
    Speaker: Aaron Mendelsohn, PhD, MPH.